Packaging plays an essential role in ensuring the sterility and quality of pharmaceutical products. Primary packaging — such as ampoules, bottles, cartridges, syringes, vials, screw caps and stoppers — is the first level of defense in preserving the product’s stability, efficacy and safety, because it is in direct contact with the pharmaceutical product.
Recently, the use of ready-to-use (RTU) packaging has increased as a promising alternative to conventional bulk primary packaging for filling and packaging pharmaceuticals. Due to benefits in product safety, filling efficiency and flexibility in small-batch production, RTU options such as pre-sterilized / pre-treated container-closure systems have become increasingly popular for pharmaceuticals.
In the future, as pharmaceutical manufacturers continue to strive for greater flexibility in their operational protocols, RTU containers and closure systems are expected to add significant value by streamlining pharmaceutical fill/finish operations.
Tyvek® is the proven packaging material preferred by the pharmaceutical RTU market due to its many properties including:
Tyvek® has been a trusted choice for medical device and pharmaceutical manufacturers as well as specialized sterile packaging suppliers worldwide for decades. When it comes to sterile packaging, choose Tyvek®.
Bart Zeedzen (Technical Sales & Business Development Manager, EMEA) recently interviewed Gregor Deutschle (Director Business Development Sterile Solutions at SCHOTT AG – Pharmaceutical Packaging) about the uses, advantages and benefits of ready-to-use (RTU) packaging for pharmaceuticals. Watch these brief videos below: